跳至主要内容
临床试验/NCT04804969
NCT04804969进行中(未招募)不适用

MyoVista wavECG Clinical Validation Study

Heart Test Laboratories, Inc.5 个研究点 分布在 1 个国家目标入组 575 人开始时间: 2021年5月10日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
575
试验地点
5
主要终点
Sensitivity and Specificity

研究概览

简要总结

Clinical validation study of the MyoVista wavECG.

详细描述

This is a multi-center, non-interventional, single arm clinical study of the MyoVista wavECG for the detection of LV relaxation abnormalities. Study subjects will be drawn from patients who are at-risk for cardiac disease and who have been referred for 2D transthoracic echocardiogram.

The study will be conducted at a minimum of three investigational sites within the United States.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with risk factors for cardiac disease or suspected of having cardiac disease during clinical assessment.
  • The subject provides written informed consent using an Informed Consent Form that is reviewed and approved by the site's Institutional Review Board (IRB).
  • Conventional ECG results show a sinus rhythm and no other contraindicated rhythm abnormalities (see exclusions below).
  • Subject is >/= 22 years of age

排除标准

  • The subject has current acute coronary syndrome, decompensated heart failure or stroke
  • The subject has received any prior cardiac interventions or surgical therapeutic procedures relating to cardiac abnormalities: valve replacement, pacemaker implantation, coronary artery bypass grafting (CABG), heart transplant, ablation, coronary stent placement, etc.
  • Conventional ECG results indicating a lack of sinus rhythm and/or any other contraindicated rhythm abnormalities, including: active atrial fibrillation or atrial flutter, left anterior fascicular block, left and/or right bundle branch block
  • The subject is pregnant at the time of the study testing
  • The subject has chest deformities that interfere with accurate measurement of ECG (either conventional or wavECG)
  • Subjects with central nervous system or musculoskeletal abnormalities that may interfere with accurate acquisition of ECG and/or echocardiogram measurements.
  • The subject is enrolled in another clinical study that may interfere with MyoVista or echocardiogram measurements. Exceptions to this may be approved by HeartSciences.

结局指标

主要结局

Sensitivity and Specificity

时间窗: Baseline

Sensitivity and specificity of the MyoVista for the classification of Low e' from echocardiogram where a "positive" includes Positive and Highly Positive MyoVista Device outcomes.

次要结局

  • Sensitivity and Specificity(Baseline)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验